» Articles » PMID: 35035844

HMSCs Migrate Under the Chemotaxis of CXCL-13 and Enhance Islet B Cell Activity Through P-AKT Signaling Pathway in High-Glucose Environment

Overview
Journal J Healthc Eng
Date 2022 Jan 17
PMID 35035844
Authors
Affiliations
Soon will be listed here.
Abstract

As a common clinical chronic disease, the incidence of diabetes is increasing year by year. According to the latest statistics from the International Diabetes Federation, as of 2019, the global prevalence of diabetes has reached 8.3%. This study aims to investigate the effect of CXCL-13 on the migration ability of human mesenchymal stem cells (hMSCs) and to clarify the specific molecular mechanism of the protective effect of hMSCs on islet B cells. The hMSCs were cultured in high-glucose environment, and the effect of CXCL-13 on the migration ability of hMSCs was determined by Transwell experiment. After coculture of hMSCs and islet B cells, the activity of cells was detected by CCK8 assay, the expression of Ki-67 in cells was detected by RT-PCR, and the expression of P53 was detected by Western blot to investigate the effect of hMSCs on the proliferation and apoptosis of islet B cells. The effect of hMSCs on the function of islet B cells was determined by glucose stimulated insulin secretion experiment. Transwell experiment results showed that CXCL-13 could promote the migration of hMSCs to islet B cells in high-glucose environment. The results of CCK-8 showed that the cell activity in the coculture group was significantly higher than that of the other groups, and RT-PCR showed that the expression of Ki-67 was significantly increased in the coculture group of hMSCs and islet B cells. The results of Western blot showed that the expression of P53 was significantly decreased in the coculture group, and the glucose stimulated insulin secretion test showed that insulin secretion was significantly increased. It was found that after the inhibition of ATK, cell activity was significantly reduced, and apoptosis was significantly increased. Meanwhile, the expression of Ki-67 was inhibited, the expression of P-53 was significantly increased, and insulin secretion was significantly reduced. To sum up, in a high-glucose environment, CXCL-13 effectively promoted the migration of hMSCs, and hMSCs protected the activity and function of islet B cells through Akt signaling pathway.

Citing Articles

Epigallocatechin gallate attenuated high glucose-induced pancreatic beta cell dysfunction by modulating DRP1-mediated mitochondrial apoptosis pathways.

Jia X, Mao D, Guo J, Ke J, Zhu Y, Zhao X Sci Rep. 2024; 14(1):16809.

PMID: 39039202 PMC: 11263710. DOI: 10.1038/s41598-024-67867-0.


Retracted: hMSCs Migrate under the Chemotaxis of CXCL-13 and Enhance Islet B Cell Activity through p-AKT Signaling Pathway in High-Glucose Environment.

Healthcare Engineering J J Healthc Eng. 2023; 2023:9804875.

PMID: 37621626 PMC: 10447126. DOI: 10.1155/2023/9804875.


The role of CXCL family members in different diseases.

Zhou C, Gao Y, Ding P, Wu T, Ji G Cell Death Discov. 2023; 9(1):212.

PMID: 37393391 PMC: 10314943. DOI: 10.1038/s41420-023-01524-9.


Research Progress on Mesenchymal Stem Cells for the Treatment of Diabetes and Its Complications.

Zhang J, Zheng Y, Huang L, He J Int J Endocrinol. 2023; 2023:9324270.

PMID: 37143697 PMC: 10151724. DOI: 10.1155/2023/9324270.


Human Umbilical Cord Mesenchymal Stem Cells Attenuate Severe Burn-Induced Multiple Organ Injury via Potentiating IGF-1 and BCL-2/BAX Pathway.

Wang H, Ba T, Wang Q, Yang L, Li C, Hao X Stem Cells Int. 2023; 2022:5474289.

PMID: 36591374 PMC: 9803581. DOI: 10.1155/2022/5474289.

References
1.
Manoylov I, Boneva G, Doytchinova I, Mihaylova N, Tchorbanov A . Protein-engineered molecules carrying GAD65 epitopes and targeting CD35 selectively down-modulate disease-associated human B lymphocytes. Clin Exp Immunol. 2019; 197(3):329-340. PMC: 6693972. DOI: 10.1111/cei.13305. View

2.
Qiu H, Ma L, Feng F . PICK1 attenuates high glucose-induced pancreatic β-cell death through the PI3K/Akt pathway and is negatively regulated by miR-139-5p. Biochem Biophys Res Commun. 2019; 522(1):14-20. DOI: 10.1016/j.bbrc.2019.11.051. View

3.
Zhang P, Zuo Z, Wu A, Shang W, Bi R, Jin Q . miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines. Oncol Lett. 2017; 13(3):1789-1796. PMC: 5403669. DOI: 10.3892/ol.2017.5654. View

4.
Bruder S, Jaiswal N, Haynesworth S . Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997; 64(2):278-94. DOI: 10.1002/(sici)1097-4644(199702)64:2<278::aid-jcb11>3.0.co;2-f. View

5.
Soltani A, Soleimani M, Ghiass M, Enderami S, Rabbani S, Jafarian A . Treatment of diabetic mice by microfluidic system-assisted transplantation of stem cells-derived insulin-producing cells transduced with miRNA. Life Sci. 2021; 274:119338. DOI: 10.1016/j.lfs.2021.119338. View